atrial fibrillation

This Week in Nature

In Nature this week: genomic regions affecting parental care in mice, and more.

A pair of studies also uncovered atrial fibrillation risk loci specific to East Asian populations, particularly near SH3PXD2A.

This Week in PLOS

In PLOS this week: ramifications of multi-nucleotide de novo mutations, circulating microRNAs and atrial fibrillation, and more.

The researchers examined nine atrial fibrillation-linked SNPs in more than 16,500 people.

ARCA aims to boost participation by easing stringent enrollment criteria in a study investigating Gencaro in heart failure patients with a favorable response genotype.

The large PGx analysis might provide welcome data for those already supportive of genotyping in the context of warfarin, but will it convince detractors?

Rosetta Genomics this week announced the publication of data by company researchers showing that downregulation of microRNA-150 is correlated to atrial fibrillation (AF) in patients with chronic systolic heart failure.

NEW YORK (GenomeWeb News) – Arca biopharma today said that Laboratory Corporation of America has told it that the US Food and Drug Administration has accepted LabCorp's investigational device exemption application for a companion diagnostic test for an atrial fibrillation drug under development.

Originally published Nov. 22.
Doctors have been in a "should we or shouldn't we" conundrum with warfarin pharmacogenetic testing for years.

Pages

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.